Neuroblastoma

14,732views

Neuroblastoma

6100

6100

Anatomy of the thyroid and parathyroid glands
Endocrine system anatomy and physiology
Hunger and satiety
Oxytocin and prolactin
Growth hormone and somatostatin
Antidiuretic hormone
Thyroid hormones
Pituitary adenoma
Gigantism
Acromegaly
Constitutional growth delay
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Pituitary apoplexy
Sheehan syndrome
Diabetes insipidus
Prolactinoma
Pituitary gland histology
Somatostatin
Hyperprolactinemia
Diabetes insipidus and SIADH: Pathology review
Achondroplasia
Growth hormone deficiency
Pharyngeal arches, pouches, and clefts
Thyroid and parathyroid gland histology
Development of the tongue
Fascia and spaces of the neck
Superficial structures of the neck: Cervical plexus
Deep structures of the neck: Root of the neck
Superficial structures of the neck: Anterior triangle
Deep structures of the neck: Prevertebral muscles
Superficial structures of the neck: Posterior triangle
Parathyroid hormone
Hyperthyroidism: Clinical
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Graves disease
Hypothyroidism
Hyperthyroidism
Toxic multinodular goiter
Hypothyroidism and thyroiditis: Clinical
Iodine deficiency
Hashimoto thyroiditis
Riedel thyroiditis
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Subacute granulomatous thyroiditis
Postpartum thyroiditis
Euthyroid sick syndrome
Cell signaling pathways
Pituitary tumors: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Parathyroid disorders and calcium imbalance: Pathology review
Hypoparathyroidism
Hypocalcemia
DiGeorge syndrome
Hyperparathyroidism
Bone remodeling and repair
Insulins
Insulin
Glucagon
Diabetes mellitus: Pathology review
Tubular reabsorption of glucose
Vitamin D deficiency
Vitamin D
Chronic kidney disease: Clinical
Hypermagnesemia
Osteoporosis medications
Hypomagnesemia
Pancreas histology
Diabetic retinopathy
Diabetic nephropathy
Diabetes mellitus
Diabetes mellitus: Clinical
Gestational diabetes
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Multiple endocrine neoplasia
MEN syndromes: Clinical
Synthesis of adrenocortical hormones
Adrenocorticotropic hormone
Cholesterol metabolism
Adrenal gland histology
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Adrenal insufficiency: Pathology review
Waterhouse-Friderichsen syndrome
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome
Cushing syndrome: Clinical
Congenital adrenal hyperplasia: Clinical
Congenital adrenal hyperplasia
Cortisol
Adrenal masses: Pathology review
Conn syndrome
Hyperaldosteronism
Miscellaneous hypoglycemics
Hypoglycemics: Insulin secretagogues
Mineralocorticoids and mineralocorticoid antagonists
Adrenal hormone synthesis inhibitors
Testosterone
Estrogen and progesterone
Precocious puberty
Virilization: Clinical
Neuroblastoma
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Adrenal masses and tumors: Clinical
Kallmann syndrome
Amenorrhea
Polycystic ovary syndrome
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Delayed puberty

Transcript

Watch video only

Neuroblastoma is a type of tumor composed of “neuroblasts,” specifically neural crest cells, which are cells involved in the development of the sympathetic nervous system.

Neuroblastoma is the most common cancer in infants, and it’s only rarely seen in children over five years old.

When a fetus is in its 5th week of development, special cells called neural crest cells start migrating along the spine.

In the thoracic region of the spine, neural crest cells differentiate into the neurons of the sympathetic chain, lying on either side of the entire spinal cord.

In the lumbar region, neural crest cells differentiate into the cells of the adrenal medulla, the inner part of the adrenal gland that sits atop the kidneys.

Together, the sympathetic chain and adrenal medulla form the sympathetic nervous system, connecting the brain and central nervous system to various organs including the heart and blood vessels.

So, when you’re under some sort of stress, like playing a competitive sport like badminton, the sympathetic nervous system kicks into action.

The sympathetic neurons releases norepinephrine, also called noradrenaline, and the cells of the adrenal medulla release norepinephrine and epinephrine, also called adrenaline.

These hormones bind to receptors in various tissues like the blood vessels, the heart, and the lungs, redirecting blood flow to your muscles, make your heart pump faster, and expanding the airways in your lungs, all of which can help you make the winning hit.

After the game is over, and the hormones are no longer needed, epinephrine and norepinephrine break down into metabolites like homovanillic acid or HMA, and vanillylmandelic acid, or VMA.

In neuroblastoma, some neural crest cells in the sympathetic chain or adrenal medulla don’t differentiate properly during fetal development, and these cells ultimately go on to form a tumor, which most often form in the adrenal medulla, but can also develop in other areas of the sympathetic chain.

While no one knows exactly how it happens, this abnormal cell differentiation has been associated with mutations in the MYCN oncogene, Anaplastic lymphoma kinase ALK fusion oncogenes, and mutations in tumor suppressor genes, like the Paired-like homeobox 2b or PHOX2B, and other tumor suppressor genes on chromosome 1 and 11.

Oncogenes help cells grow and proliferate, while tumor suppressor genes slow down cell growth and proliferation.

So both an MYCN amplification or ALK gene fusion, where the oncogene is “turned on,” or a PHOX2B and chromosome 1 and 11 deletions, where tumor suppressor genes are “turned off,” can potentially cause uncontrolled cell growth.

There are three types of neuroblastomas, and they’re categorized based on the size and shape of the tumor cells: undifferentiated, poorly differentiated, and differentiating neuroblastoma.

An undifferentiated neuroblastoma is mostly comprised of neural crest cells, which are sometimes called small round blue cells, due to a lack of cytoplasm, and a large blue nuclei.

A poorly differentiated neuroblastoma is composed of slightly more differentiated cells, with smaller nuclei and a bit more cytoplasm.

In addition, the cells of a poorly differentiated neuroblastoma may be surrounded by a substance called neuropil, which is a dense network of interwoven nerve fibers, like axon and dendrite branches.

Finally, a differentiating neuroblastoma is composed of cells with lots of cytoplasm, and is often surrounded by a substance called Schwannian stroma.

Schwannian stroma is a connective tissue from non-neuronal cells that forms myelin, which insulates the axons of the mature neurons.

When any type of neuroblastoma forms, cells in the surrounding tissue release chemokines called CXCL12 and that stimulates nearby immune cells.

CXCL12 is normally produced by some organs like the lymph nodes, liver, bones, and especially the bone marrow, but gets produced in higher amounts when tissue is damaged.

Key Takeaways

Neuroblastoma is a type of tumor composed of neural crest cells, which are cells involved in the development of the sympathetic nervous system. It is most commonly found in the adrenal gland, but it can also occur in other parts of the body along the sympathetic chain, such as the neck, chest, or pelvis. Neuroblastoma most often affects children, and it is more common in males than in females.

Symptoms of neuroblastoma can vary depending on the location and size of the tumor. They may include abdominal pain, a lump in the abdomen, difficulty breathing, bone pain, weight loss, sweating, fatigue, and changes in bowel or bladder function. Treatment for neuroblastoma may include surgery to remove the tumor, chemotherapy, radiation therapy, and immunotherapy.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison’s principles of internal medicine" McGraw Hill / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Neuroblastoma Origin and Therapeutic Targets for Immunotherapy" Journal of Immunology Research (2018)
  7. "Neuroblastoma pathogenesis: deregulation of embryonic neural crest development" Cell and Tissue Research (2017)
  8. "Integrative genomics identifies LMO1 as a neuroblastoma oncogene" Nature (2010)